| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5594384 | American Heart Journal | 2017 | 10 Pages |
Abstract
Only one-third of percutaneous coronary intervention-treated MI patients with high on-clopidogrel platelet reactivity were switched to a more potent P2Y12 receptor inhibitor. Intensification of antiplatelet therapy was associated with lower risk of ischemic events at 1Â year among HPR patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Akshay MD, MHS, Eric D. MD, MPH, Lisa A. MS, Mark B. MD, Marjorie E. PhD, MPH, Gregg W. MD, Timothy D. MD, David J. MD, Phillip J. PhD, Kevin J. PhD, Tracy Y. MD, MHS, MSc,